
Abrdn
Europe, Edinburgh, City of, United Kingdom, Edinburgh'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Abrdn enables its clients to plan, save, and invest for their futures.
Investor Profile
Abrdn has made 20 investments, with 7 in the past 12 months and 15% as lead.
Stage Focus
- Series A (20%)
- Series B (20%)
- Series C (15%)
- Private Equity (15%)
- Series Unknown (10%)
- Post Ipo Equity (5%)
- Post Ipo Debt (5%)
- Debt Financing (5%)
- Post Ipo Secondary (5%)
Country Focus
- United States (45%)
- United Kingdom (25%)
- Canada (10%)
- India (5%)
- Argentina (5%)
- Finland (5%)
- Malaysia (5%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Medical
- Financial Services
- Software
- Pharmaceutical
- Therapeutics
- Oncology
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.